Nebulised salbutamol administered during sputum induction improves bronchoprotection in patients with asthma
Open Access
- 1 February 2004
- Vol. 59 (2), 111-115
- https://doi.org/10.1136/thorax.2003.011130
Abstract
Background: Inhalation of hypertonic or even isotonic saline during sputum induction may cause bronchospasm in susceptible patients with asthma, despite premedication with 400 µg inhaled salbutamol delivered by pressurised metered dose inhaler (pMDI). The bronchoprotection afforded by additional inhaled salbutamol administered through the ultrasonic nebuliser during sputum induction was investigated. Methods: Twenty patients with moderate to severe asthma underwent sputum induction by inhaling saline 4.5% (or 0.9% if post-bronchodilation forced expiratory volume in 1 second (FEV1) 1 was recorded during sputum induction at 1, 3, 5, and 10 minutes. Sputum cell counts and histamine, tryptase and albumin levels in the supernatants were determined. Results: The mean (SE) maximal reduction in FEV1 over the 10 minute period of sputum induction was 11.7 (2.8)% at visit A, which was significantly greater than at visit B (2.6 (1.2)%; mean difference 9% (95% CI 2.7 to 15.4), pConclusion: The addition of inhaled salbutamol through an ultrasonic nebuliser markedly improves bronchoprotection against saline induced bronchoconstriction in patients with moderate to severe asthma undergoing sputum induction without affecting cell counts and inflammatory markers.Keywords
This publication has 19 references indexed in Scilit:
- Smoking and mortality from tuberculosis and other diseases in India: retrospective study of 43 000 adult male deaths and 35 000 controlsThe Lancet, 2003
- Indirect airway challengesEuropean Respiratory Journal, 2003
- Long-acting Inhaled β2-Agonist Therapy in AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Sputum Induction in Severe Asthma by a Standardized ProtocolAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Functional antagonism: tolerance produced by inhaled beta 2 agonists.Thorax, 1996
- Comparative nasal effects of bradykinin and histamine: influence on nasal airways resistance and plasma protein exudation.Thorax, 1993
- Use of induced sputum cell counts to investigate airway inflammation in asthma.Thorax, 1992
- The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.Thorax, 1991
- Hypertonic saline increases vascular permeability in the rat trachea by producing neurogenic inflammation.JCI Insight, 1990
- Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline.BMJ, 1981